Comparison between Dr Lalchandani Labs IPO and Indo US Bio-Tech IPO.
IPO Details
Dr Lalchandani Labs IPO is a SME Fixed Price IPO proposed to list at BSE SME while Indo US Bio-Tech IPO is a SME Fixed Price proposed to list at BSE SME.
The total issue size of Dr Lalchandani Labs IPO is up to ₹3.98 Cr whereas the issue size of the Indo US Bio-Tech IPO is up to ₹6.92 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of Indo US Bio-Tech IPO is ₹51.00 per share.
Dr Lalchandani Labs IPO opens on Apr 25, 2018, while Indo US Bio-Tech IPO opens on Apr 30, 2018. The closing date of Dr Lalchandani Labs IPO and Indo US Bio-Tech IPO is Apr 27, 2018, and May 03, 2018, respectively.
In the Dr Lalchandani Labs IPO Retail Individual Investors (RII) are offered 6,64,000 shares while in Indo US Bio-Tech IPO retail investors are offered 6,64,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Dr Lalchandani Labs IPO and 0 shares in Indo US Bio-Tech IPO.
